Alterity Therapeutics Ltd.ASX: ATH

Alterity Launches ATH434 Phase 2 Clinical Trial

Jun 2, 2022 at 4:19 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment